Days of follow-up | D0 | D1 | D2 | D3 | D7 | D14 | D21 | D28 |
---|---|---|---|---|---|---|---|---|
2011 | ||||||||
Patients observed (n) | 37 | 37 | 37 | 36 | 36 | 35 | 35 | 35 |
Microscopy (+) | 37 (100) | 25 (67.5) | 8 (21.6) | 4 (11) | 1 (2.8) | 0 | 0 | 1 (2.8) |
PCR (+) | 37 | 34 (92) | 20 (54) | 13 (36) | 8 (22) | 4 (11) | 1 (2.8) | 1 (2.8) |
2012 | ||||||||
Patients observed (n) | 33 (100) | 33 | 33 | 33 | 33 | 32 | 31 | 31 |
Microscopy (+) | 33 | 27 (82) | 6 (18) | 4 (12) | 2 (6) | 1 (3) | 0 | 0 |
PCR (+) | 33 | 30 (91) | 19 (58) | 14 (42) | 10 (30) | 1 (3) | 0 | 0 |
2013 | ||||||||
Patients observed (n) | 33 | 33 | 33 | 33 | 33 | 29 | 29 | 29 |
Microscopy (+) | 33 (100) | 30 (91) | 6 (18) | 5 (15) | 3 (9) | 0 | 0 | 1 (3.4) |
PCR (+) | 33 | 33 (100) | 30 (91) | 21 (63.6) | 17 (51.5) | 11 (38) | 5 (17) | 3 (10) |
Total | ||||||||
Patients observed (n) | 103 | 103 | 103 | 102 | 102 | 96 | 95 | 95 |
Microscopy (+) | 103 (100) | 82 (80) | 20 (19) | 13 (13) | 6 (6) | 1 (1) | 0 | 2 (2) |
PCR (+) | 103 | 97 (94) | 69 (67) | 48 (47) | 35 (34) | 16 (17) | 6 (6) | 4 (4) |